Elanco Animal Health downgraded by Morgan Stanley with a new price target
$ELAN
Biotechnology: Pharmaceutical Preparations
Health Care
Morgan Stanley downgraded Elanco Animal Health from Overweight to Equal-Weight and set a new price target of $22.00 from $37.00 previously